I keep telling myself lately that I really shouldn't miss #ESCMIDGlobal and this interesting thread by Onisillos is confirming that. I’ll definitely have to make a plan to attend in the future.🤔
#Escmidglobal
👋Closing out #ESCMIDGlobal
Grateful for the many conversations over the past few days.
🙏 Thank you to everyone who joined us at the booth and poster sessions. Your questions and perspectives are what make these spaces meaningful.
@escmid.bsky.social
🤝 This perspective from Jennifer Zinn shared at #ESCMIDGlobal 2026 in Munich really stood out to me.
http://share.biomerieux.com/813h6mG1F6uM #ESCMIDGlobal http://share.biomerieux.com/WoMhk7UoB3xG
Just presented at #ESCMIDGlobal
Across 29 gonorrhoea studies in Cambodia, Thailand, Vietnam and South Africa, only 4 include susceptibility data. NAAT-based diagnostics dominate, limiting resistance tracking. Significant surveillance gaps remain.
🤝 Still at Booth G71, come say hi to us!
Presenting our last poster at #ESCMIDGlobal today.
📍12:00–13:30, Poster Hall B3
Our poster looks at surveillance gaps in gonorrhoea across Cambodia, Thailand, Vietnam and South Africa — from missing regional data to limited resistance insights driven by diagnostic choices.
🧪📊 We just presented at #ESCMIDGlobal.
Carbapenem-resistant Klebsiella pneumoniae in South Africa isn't a single strain story. We're seeing OXA-48-like enzymes, growing NDM presence and resistance to common treatments, making clinical decisions increasingly difficult.
Guideline questions have traditionally come from experts and existing guidelines. Now, patient data, web searches, and LLMs can surface what patients actually ask.
👉 A shift toward truly patient-centred evidence
#ESCMIDGlobal #AIinHealthcare #PatientCentredCare
📄 Presenting today at 17:30 in Arena 3 at #ESCMIDGlobal.
Our poster looks at carbapenem-resistant Klebsiella pneumoniae in South Africa where the resistance landscape is far more diverse and complex than a single strain story.
Here’s a thread on the talk I gave at #ESCMIDGlobal 2026:
“Toilets: Flushing and Spread of Pathogens” — nicknamed “You can’t outrun the plume.” Using published studies, I covered the key components shown below. There’s a surprising amount of data, but still a lack of high-quality intervention trials
Bit overwhelming to be among 15000 microbiologists at #ESCMIDGlobal in #Munich… but fun to see so many friends and colleagues! If you here…. Reach out!
Just presented at #ESCMIDGlobal!
STI guidelines in South Africa are widely followed, but consistent delivery is shaped by workflow and stock realities. Improving guidelines isn't always the main challenge, implementation is. Strong support for new oral gonorrhoea treatments too.
🤝 Visit Booth G71
📄 We're presenting our first poster at #ESCMIDGlobal.
📍Poster Hall B3
Our South Africa work looks at how STI guidelines translate into practice and what shapes uptake on the ground. We're also exploring attitudes toward a new oral gonorrhoea treatment.
If you’re at the conference, join us!
Checkout session O0678 14:18 List of Recommended Names (LoRN) for Bacteria of Medical Importance
#ECCMID 💉🧫🦠🔬#IDSky
#ESCMIDGLOBAL 2026
The LoRN recommends stable names rather than just the latest validly published name, provides
guidance on the use of established nomenclature in clinical routines.
A lot will be shared at #ESCMIDGlobal.
But some of the most important conversations happen between sessions.
🔴🪧 We’re at Booth G71 if you want to connect with our team.
@escmid.bsky.social
Day 1 at #ESCMIDGlobal in Munich – great energy, inspiring first talks, and fantastic to reconnect with colleagues worldwide. Looking forward to the next days: exciting sessions, discussions, and new insights with our team. Stay tuned! #InfectiousDiseases #AMR
Infectious diseases research endpoints such as mortality are the most common outcomes observed.
But what if we don’t have to use mortality all the time?
Drs. Calbo and Katsounas provided excellent info on ways we can include other outcomes in research!
#IDXPosts #ESCMIDGlobal
🔴 We’re live at #ESCMIDGlobal 2026
Munich is now home to five days of conversations on AMR, infectious diseases, clinical microbiology and what comes next.
Meet the team at Booth G71👋
@escmid.bsky.social
Excited to be in #Munich for #ESCMIDGlobal 2026!
Honored to serve as a social media ambassador this year - I’ll be live posting key sessions and takeaways throughout the meeting.
If you’re presenting and would like your work highlighted, feel free to reach out. Looking forward to a great week!
The GSL team will be at #ESCMIDGlobal (Apr 17–21, Munich). Let’s connect if you’re attending!
🎤 Don’t miss Geneviève Boily-Larouche: “Promoting global research agendas for policymakers” 🗓️ Apr 20 | 🕠 18:15
@mathieujpp.bsky.social @escmid.bsky.social
Just done some last minute pruning of my #ESCMIDGlobal agenda. It was really difficult to decide between overlapping sessions.
Our REVIVE team will also be at #ESCMIDGlobal. REVIVE supports the antimicrobial R&D community by connecting researchers with experienced antibiotic developers and creating spaces for learning and knowledge exchange.
If you’re working in this space, come meet the team at our Booth G71!
We’ll be at #ESCMIDGlobal this April ✈️
If you’re in Munich, stop by Booth G71, attend our poster presentations and meet the GARDP team working across antibiotic R&D and access.
📅17–21 April | Munich
@escmid.bsky.social
📢 The April REVERSE Project newsletter now available!
This edition features:
• #ESCMIDGlobal project activities
• REVERSE Conference early-bird registration
• Recent Activities
🔗Stay informed & discover the latest bit.ly/4dyUFw1
#AMR #Science #PublicHealth #InfectiousDiseases #IDSky #ResearchSky
💡There are still hotel rooms available with our official congress partners at Congrex Switzerland. Book today and see you soon in Munich at #ESCMIDGlobal! https://ow.ly/XWQx50YCoSM
#IDSky #clinmicro
Join the Young Investigator Workshop at #ESCMIDGlobal 2026 for practical insights and science you can actually use!
Early-career investigators are driven to deliver meaningful research, but navigating the “how” isn’t always straightforward.
📍 Room 2 (ICM Ground Floor)
👉 bit.ly/4uKdN0r
Just done my first pass of the #ESCMIDglobal programme. So much good stuff! I’m going to have to whittle down my list already. But let me know if you recommend any sessions.
#ESCMIDglobal2026
It’s that time of year again – #ESCMIDGlobal 2026 🌍is happening in Munich from April 17–21
#PioneeringDiagnostics #OptimizeDiagnostics http://share.biomerieux.com/ySwYwF6dxutQ
Looking ahead to #ESCMIDGlobal 2026 in Munich, we’re reflecting on the energy & collaboration from Vienna last year. Great to connect with so many experts & partners advancing ID research. Excited to continue these conversations in Munich.
Will you be there? Visit us at booth F21: bit.ly/474r0qy
It’s that time of year again – #ESCMIDGlobal 2026 🌍is happening in Munich from April 17–21 http://share.biomerieux.com/XzfUUMoH6FJt
It’s that time of year again – #ESCMIDGlobal 2026 🌍is happening in Munich from April 17–21
If you’re attending, make sure to stop by Booth A70 http://share.biomerieux.com/2mreg92R137w